Lignopad Medicated Plaster 5% w/w

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Bahan aktif:

LIDOCAINE

Boleh didapati daripada:

MUNDIPHARMA PHARMACEUTICALS SDN. BHD.

INN (Nama Antarabangsa):

LIDOCAINE

Unit dalam pakej:

20Pieces Pieces; 10Pieces Pieces; 30Pieces Pieces; 10 Pieces Pieces; 20 Pieces Pieces; 30 Pieces Pieces

Dikeluarkan oleh:

TEIKOKU SEIYAKU CO LTD

Ciri produk

LIGNOPAD® 5% MEDICATED PLASTER
COMPOSITION
Each 10 cm x 14 cm plaster contains 700 mg (5% w/w) lidocaine (50 mg
lidocaine per gram adhesive
base)
PHARMACEUTICAL FORM
MEDICATED PLASTER
White hydrogel plaster containing adhesive material, which is applied
to a non-woven polyethylene
terephthalate backing embossed with “Lidocaine 5%” and covered
with a polyethylene terephthalate
film release liner.
THERAPEUTIC INDICATIONS
_LIGNOPAD®_ medicated plaster is indicated for the symptomatic relief
of neuropathic pain associated with
previous herpes zoster infection (post-herpetic neuralgia, PHN).
POSOLOGY AND METHOD OF ADMINISTRATION
ADULTS AND ELDERLY PATIENTS
The painful area should be covered with the plaster once daily for up
to 12 hours within a 24 hours
period. Only the number of plasters that are needed for an effective
treatment should be used. When
needed, the plasters may be cut into smaller sizes with scissors prior
to removal of the release liner. In
total, not more than three plasters should be used at the same time.
The plaster must be applied to intact, dry, non-irritated skin (after
healing of the shingles).
Each plaster must be worn no longer than 12 hours. The subsequent
plaster-free interval must be at
least 12 hours.
The plaster must be applied to the skin immediately after removal from
the sachet and following
removal of the release liner from the gel surface. Hairs in the
affected area must be cut off with a pair of
scissors (not shaved).
Treatment outcome should be re-evaluated after 2-4 weeks. If there has
been no response to _LIGNOPAD®_
medicated plaster after this period or if any relieving effect can
solely be related to the skin protective
properties of the plaster, treatment must be discontinued. Treatment
should be reassessed at regular
intervals to decide whether the amount of plasters needed to cover the
painful area can be reduced, or
if the plaster-free period can be extended.
Use for patients under the age of 18 is not recommended because of the
lack of data in this group.
CONTRAIN